Evidence map›Paper›PMID 32914275›Full record

SynthesisLasers in medical science2021

Non-excisional laser therapies for hemorrhoidal disease: a systematic review of the literature.

Gregoire Longchamp, Emilie Liot, Jeremy Meyer, Christian Toso, Nicolas C Buchs, Frederic Ris

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Lasers in medical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 5 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 5 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Gregoire LongchampDivision of Digestive Surgery, Geneva University Hospitals and Medical School, Geneva, Switzerland.ORCID https://orcid.org/0000-0003-0031-4707
Emilie LiotDivision of Digestive Surgery, Geneva University Hospitals and Medical School, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-2856-5260
Jeremy MeyerDivision of Digestive Surgery, Geneva University Hospitals and Medical School, Geneva, Switzerland.ORCID https://orcid.org/0000-0003-3381-9146
Christian TosoDivision of Digestive Surgery, Geneva University Hospitals and Medical School, Geneva, Switzerland.ORCID https://orcid.org/0000-0003-1652-4522
Nicolas C BuchsDivision of Digestive Surgery, Geneva University Hospitals and Medical School, Geneva, Switzerland.ORCID https://orcid.org/0000-0001-9255-3929
Frederic RisDivision of Digestive Surgery, Geneva University Hospitals and Medical School, Geneva, Switzerland. frederic.ris@hcuge.ch.ORCID https://orcid.org/0000-0001-7421-6101
University Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-excisional laser therapies are emerging treatment for grades II and III hemorrhoidal disease (HD). However, so far, their efficiency is based on low-level evidence. Therefore, we aimed to systematically review the efficiency of non-excisional laser therapies for HD. MEDLINE/Pubmed, Web of science, Embase, and Cochrane were searched from database implementation until the April 17th, 2020. We included studies reporting at least one of surgical indicators of postoperative outcomes of laser therapies, encompassing laser hemorrhoidoplasty (LH) and hemorrhoidal laser procedure (HeLP). Fourteen studies describing LH and HeLP were included, representing 1570 patients. The main intraoperative complication was bleeding (0-1.9% of pooled patients for LH, 5.5-16.7% of pooled patients for HeLP). Postoperative complications occurred in up to 64% of patients after LH and 23.3% after HeLP. Resolution of symptoms ranged between 70 and 100% after LH and between 83.6 and 90% after HeLP. Moreover, four randomized controlled trials included in our review reported similar resolution after LH compared with hemorrhoidectomy or mucopexy and after HeLP compared with rubber band ligation. Recurrence rate was reported to range between 0 and 11.3% after LH and between 5 and 9.4% after HeLP. When compared with hemorrhoidectomy, LH showed conflicting results with one randomized controlled trial reporting similar recurrence rate, but another reporting decreased recurrences associated with hemorrhoidectomy. Laser therapies showed lower postoperative pain than hemorrhoidectomy or rubber band ligation. LH and HeLP are safe and effective techniques for the treatment of grades II and III HD.

Indexed as

Laser TherapyFemaleHemorrhoidectomyHemorrhoidsHumansMaleMiddle AgedPerioperative CarePostoperative PainQuality of LifeRecurrenceReoperationTreatment OutcomeComplicationsHemorrhoidsLaserOutcomes

Identifiers

PMID32914275
PMCPMC7952353
OpenAlexW3084501777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.